Related Experiment Video
Updated: Jul 10, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV-1 integrase inhibitors: 2005-2006 update
Raveendra Dayam1, Rambabu Gundla, Laith Q Al-Mawsawi
1Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, Los Angeles, California 90089, USA.
Medicinal Research Reviews
|November 6, 2007
Summary
New HIV-1 integrase inhibitors are crucial due to drug resistance. This review details compounds discovered in 2005-2006, offering potential new antiretroviral therapies.
Area of Science:
- Virology
- Medicinal Chemistry
- Drug Discovery
Background:
- HIV-1 integrase (IN) is essential for viral replication, making it a key target for antiretroviral therapy.
- Existing IN inhibitors like MK-0518 and GS-9137 show efficacy but face challenges from drug-resistant viral strains.
- The dynamic nature of the HIV-1 genome necessitates the continuous development of novel inhibitors.
Purpose of the Study:
- To comprehensively review HIV-1 integrase inhibitors discovered during 2005 and 2006.
- To highlight diverse chemical classes of novel IN inhibitors.
- To inform ongoing drug discovery efforts against HIV-1.
Main Methods:
- Literature search for peer-reviewed publications and patents.
- Identification and categorization of novel HIV-1 integrase inhibitors reported between January 2005 and December 2006.
- Analysis of chemical structures and reported biological activities.
Main Results:
- A range of novel HIV-1 integrase inhibitors from various chemical scaffolds were identified.
- Compounds demonstrated varying degrees of inhibitory activity against HIV-1 integrase.
- The review consolidates information on emerging IN inhibitor candidates.
Conclusions:
- Continued discovery of novel HIV-1 integrase inhibitors is vital to combat drug resistance.
- The compounds reported in 2005-2006 represent important advancements in antiretroviral drug design.
- Further research is warranted to develop these novel inhibitors into effective therapeutic agents.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...